GW Pharmaceuticals PLC Holding(s) in Company (7084Y)

TIDMGWP

RNS Number : 7084Y

GW Pharmaceuticals PLC

03 December 2014

 
 
 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 
------------------------------------------------------------------------------------------ 
 
 1. Identity of the issuer or the underlying                 GW Pharmaceuticals plc 
  issuer 
  of existing shares to which voting rights 
  are 
  attached: 
----------------------------------------------------  ------------------------------------ 
 2 Reason for the notification (please tick the appropriate box or boxes): 
------------------------------------------------------------------------------------------ 
 An acquisition or disposal of voting rights                                          X 
---------------------------------------------------------------------------------  ------- 
 An acquisition or disposal of qualifying financial instruments 
  which may result in the acquisition of shares already issued to 
  which voting rights are attached 
---------------------------------------------------------------------------------  ------- 
 An acquisition or disposal of instruments with similar economic 
  effect to qualifying financial instruments 
---------------------------------------------------------------------------------  ------- 
 An event changing the breakdown of voting rights 
---------------------------------------------------------------------------------  ------- 
 Other (please 
  specify): 
------------------  -------------------------------------------------------------  ------- 
 3. Full name of person(s) subject                 The Capital Group Companies, Inc. 
  to the 
  notification obligation: 
------------------------------------------  ---------------------------------------------- 
 4. Full name of shareholder(s)                 Capital Research and Management Company 
  (if different from 3.): 
------------------------------------------  ---------------------------------------------- 
 5. Date of the transaction and date                        1 December 2014 
  on 
  which the threshold is crossed 
  or 
  reached: 
------------------------------------------  ---------------------------------------------- 
 6. Date on which issuer notified:                          2 December 2014 
------------------------------------------  ---------------------------------------------- 
 7. Threshold(s) that is/are crossed                           Above 11% 
  or 
  reached: 
------------------------------------------  ---------------------------------------------- 
 
 
 
 8. Notified details: 
------------------------------------------------------------------------------------------------------------------------ 
 A: Voting rights attached to shares 
------------------------------------------------------------------------------------------------------------------------ 
 Class/type       Situation previous                    Resulting situation after the triggering 
  of               to the triggering                     transaction 
  shares           transaction 
 
  if possible 
  using 
  the ISIN CODE 
---------------  ------------------------------------  ----------------------------------------------------------------- 
                  Number           Number               Number     Number of voting         % of voting rights 
                   of               of                  of          rights 
                   Shares           Voting              shares 
                                    Rights 
---------------  ---------------  -------------------  ---------  -----------------------  ----------------------------- 
                                                        Direct     Direct      Indirect     Direct         Indirect 
---------------    -----  ------  ------  -----  ----  ---------  ----------  -----------  -------------  -------------- 
      ADRs 
 (US36197T1034)     2,135,921          25,631,053                              26,205,841                     11.072% 
---------------  ---------------  -------------------  ---------  ----------  -----------  -------------  -------------- 
 
 B: Qualifying Financial Instruments 
------------------------------------------------------------------------------------------------------------------------ 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------------------------ 
 Type of financial         Expiration      Exercise/                    Number of voting             % of voting 
  instrument                date            Conversion Period            rights that may              rights 
                                                                         be 
                                                                         acquired if the 
                                                                         instrument is 
                                                                         exercised/ converted. 
------------------------  --------------  ---------------------------  ---------------------------  -------------------- 
           n/a 
------------------------  --------------  ---------------------------  ---------------------------  -------------------- 
 
 C: Financial Instruments with similar economic effect to Qualifying Financial 
  Instruments 
------------------------------------------------------------------------------------------------------------------------ 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------------------------ 
 Type of            Exercise       Expiration     Exercise/        Number of voting             % of voting rights 
 financial           price          date           Conversion       rights instrument 
 instrument                                        period           refers to 
-----------------  -------------  -------------  ---------------  ---------------------------  ------------------------- 
       n/a                                                                                      Nominal       Delta 
-----------------  -------------  -------------  ---------------  ---------------------------  ------------  ----------- 
 
 
 Total (A+B+C) 
------------------------------------------------------------------------------------------------------------------------ 
 Number of voting rights                                         Percentage of voting rights 
--------------------------------------------------------------  -------------------------------------------------------- 
                          26,205,841                                                     11.072% 
--------------------------------------------------------------  -------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the voting rights and/or 
  the 
  financial instruments are effectively held, if applicable: 
-------------------------------------------------------------------------------- 
 
   Holdings by Capital Research and Management Company SMALLCAP World Fund, 
   Inc. 
 
 Proxy Voting: 
-------------------------------------------------------------------------------- 
 10. Name of the proxy holder: 
---------------------------------------------------  --------------------------- 
 11. Number of voting rights proxy holder will 
  cease 
  to hold: 
---------------------------------------------------  --------------------------- 
 12. Date on which proxy holder will cease to 
  hold 
  voting rights: 
---------------------------------------------------  --------------------------- 
 
 
  13. Additional information: 
----------------------------------------  -------------------------------------- 
 14. Contact name:                         Christopher Aquino 
----------------------------------------  -------------------------------------- 
 15. Contact telephone number:             800-421-8511 
----------------------------------------  -------------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLEAPADEAELFEF